Anticoagulants

Latest News

FDA
FDA OKs Oral Blood Thinner for Children

June 23rd 2021

The FDA approved Pradaxa (dabigatran etexilate) to treat venous thromboembolism in children aged 3 months to less than 12 years.

Coronavirus
Anticoagulants Improve Survival Rates in Patients With COVID-19

June 1st 2020

Time
Time of Day for Taking Warfarin Does Not Affect Anticoagulation Stability

January 27th 2020

Sickel cells
Crizanlizumab for Sickle Cell Pain Reduction Approved by FDA

November 15th 2019

Wilate product image
Wilate Approved for Hemophilia A Treatment

October 9th 2019

Latest CME Events & Activities

Influenza Prevention in the At-Risk Adult Population and the Pharmacist’s Role in an Evolving Influenza Vaccine Landscape

View More

Utilizing Targeted Agents for Treatment of HFrEF: The Role of the Pharmacist in Medication Selection and Therapy Management

1.0 Credit / Cardiology

View More

Expert Insight on Advances in the Therapeutic Landscape of Hypertrophic Cardiomyopathy

1 Credit / Cardiology

View More

Redefining Optimal Therapy for Patients with Heart Failure with Reduced Ejection Fraction: Integrating New Guidelines, Emerging Agents, and Pharmacist-led Transitions of Care

1.5 Credits / Cardiology

View More

The Impact of PCSK9 Modulation on Cardiovascular Outcomes: Recent Advances and the Managed Care Implications

1.5 Credits / Cardiology

View More

Targeting the Clinical Course of Hypertrophic Cardiomyopathy: Keeping a Beat on New and Emerging Therapies

2.0 Credits / Cardiology

View More

The Management of HFrEF With New and Emerging Mechanisms of Action: Updates for Pharmacists

1.5 Credits / Cardiology

View More

Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels

0.75 Credit / Cardiology

View More

Introduction to Anticoagulation and the Appropriate Patient

1.0 Credit / Cardiology

View More

The Treatment Landscape and a Review of Approved DOAC Agents

1.0 Credit / Cardiology

View More

The Role of the Pharmacist in Optimizing DOAC Utilization Across Practice Settings

1.0 Credit / Cardiology

View More

Understanding the Challenges of Homozygous Familial Hypercholesterolemia

1.0 Credit / Cardiology

View More

Navigating the Therapeutic Landscape of Homozygous Familial Hypercholesterolemia

1.0 Credit / Cardiology

View More

Maximizing Patient Outcomes Through Pharmacist-Led Homozygous Familial Hypercholesterolemia Management

1.0 Credit / Cardiology

View More

More News

© 2023 MJH Life Sciences

All rights reserved.